On this page · 4 sections→
Where the EU money came from
Funding by EU programme. Amounts are EpiEndo Pharmaceuticals ehf's own share of each project, not the project's full budget.
- Horizon 2020€2.5M · 2 projects
Projects
2 EU-funded projects, newest first. EpiEndo Pharmaceuticals ehf led 2 of them as coordinator. Each links to the official record.
- BRONCHOTHELINCoordinator
The first-in-class disease-modifying drug for chronic airway disorders
Horizon 2020 · 2020–2021 · Project on CORDIS ↗
€2.5Mtheir share - BronchomycnCoordinator
First in class epithelial Barrier-enhancing medicine for respiratory diseases
Horizon 2020 · 2017–2017 · Project on CORDIS ↗
€50ktheir share
Fields it works in
Research fields recorded on its Horizon projects.
- antibiotic resistance
- antibiotics
- asthma
- coronaviruses
- drug discovery
- inflammatory bowel disease
- inflammatory diseases
- mortality
- stem cells
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.